{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T17:52:39Z","timestamp":1657561959476},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s55116","type":"journal-article","created":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T00:22:17Z","timestamp":1433290937000},"page":"889","source":"Crossref","is-referenced-by-count":1,"title":["Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma"],"prefix":"10.2147","author":[{"given":"Suzanne","family":"Bollmeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Prosser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,6]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=25294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:37:17Z","timestamp":1477867037000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/fluticasone-formoterol-a-systematic-review-of-its-potential-role-in-th-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s55116","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}